J. Jeffry Howbert

1.8k total citations
38 papers, 1.5k citations indexed

About

J. Jeffry Howbert is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, J. Jeffry Howbert has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 11 papers in Organic Chemistry. Recurrent topics in J. Jeffry Howbert's work include Neuropeptides and Animal Physiology (12 papers), Receptor Mechanisms and Signaling (9 papers) and Pharmacogenetics and Drug Metabolism (4 papers). J. Jeffry Howbert is often cited by papers focused on Neuropeptides and Animal Physiology (12 papers), Receptor Mechanisms and Signaling (9 papers) and Pharmacogenetics and Drug Metabolism (4 papers). J. Jeffry Howbert collaborates with scholars based in United States, Canada and Japan. J. Jeffry Howbert's co-authors include Paul A. Wender, Robert F. Bruns, Bruce D. Gitter, Diane C. Waters, Tatsuya Tamaoki, Hirofumi Nakano, ISAMI TAKAHASHI, Eiji Kobayashi, Freeman D. Miller and William F. Heath and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and Biochemical and Biophysical Research Communications.

In The Last Decade

J. Jeffry Howbert

38 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Jeffry Howbert United States	20	804	532	352	253	125	38	1.5k
Gina H. Lu United States	21	1.1k 1.4×	388 0.7×	460 1.3×	180 0.7×	132 1.1×	32	2.0k
Wha Bin Im United States	28	1.4k 1.8×	771 1.4×	435 1.2×	177 0.7×	165 1.3×	85	2.3k
Raymond E. Gibson United States	26	886 1.1×	559 1.1×	146 0.4×	130 0.5×	124 1.0×	71	1.7k
Margot W. Beukers Netherlands	27	1.0k 1.3×	418 0.8×	410 1.2×	103 0.4×	114 0.9×	42	1.9k
S. Bajusz Hungary	24	1.2k 1.4×	877 1.6×	200 0.6×	300 1.2×	226 1.8×	84	1.9k
John Krupinski United States	13	888 1.1×	468 0.9×	176 0.5×	150 0.6×	80 0.6×	16	1.3k
Jeff D. Reagan United States	19	1.1k 1.3×	392 0.7×	225 0.6×	477 1.9×	159 1.3×	30	2.2k
Stephen R. Fletcher United States	20	941 1.2×	323 0.6×	640 1.8×	97 0.4×	182 1.5×	38	1.8k
David J. Wustrow United States	20	746 0.9×	491 0.9×	611 1.7×	194 0.8×	207 1.7×	54	1.7k
Dane Liston United States	19	752 0.9×	588 1.1×	307 0.9×	269 1.1×	131 1.0×	43	1.6k

Countries citing papers authored by J. Jeffry Howbert

Since Specialization

Citations

This map shows the geographic impact of J. Jeffry Howbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Jeffry Howbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Jeffry Howbert more than expected).

Fields of papers citing papers by J. Jeffry Howbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Jeffry Howbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Jeffry Howbert. The network helps show where J. Jeffry Howbert may publish in the future.

Co-authorship network of co-authors of J. Jeffry Howbert

This figure shows the co-authorship network connecting the top 25 collaborators of J. Jeffry Howbert. A scholar is included among the top collaborators of J. Jeffry Howbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Jeffry Howbert. J. Jeffry Howbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jackson, Randy W., et al.. (2003). Identification of TNF-α inhibitors from a split-Pool library based on a tyrosine-Proline peptidomimetic scaffold. Bioorganic & Medicinal Chemistry Letters. 13(2). 205–208. 9 indexed citations

Jackson, Randy W., Richard Gelinas, Thomas C. Cox, et al.. (2002). Benzobicyclooctanes as novel inhibitors of TNF-α signaling. Bioorganic & Medicinal Chemistry Letters. 12(7). 1093–1097. 7 indexed citations

Palmour, Roberta M., John Mulligan, J. Jeffry Howbert, & Frank R. Ervin. (1997). Of Monkeys and Men: Vervets and the Genetics of Human-Like Behaviors. The American Journal of Human Genetics. 61(3). 481–488. 35 indexed citations

Gehlert, Donald R., Susan K. Hemrick-Luecke, Douglas A. Schober, et al.. (1995). (R)-thionisoxetine, a potent and selective inhibitor of central and peripheral norepinephrine uptake. Life Sciences. 56(22). 1915–1920. 17 indexed citations

Gehlert, Donald R., Douglas A. Schober, Susan K. Hemrick-Luecke, et al.. (1995). Novel halogenated analogs of tomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain. Neurochemistry International. 26(1). 47–52. 32 indexed citations

Gitter, Bruce D., Robert F. Bruns, J. Jeffry Howbert, et al.. (1995). Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 275(2). 737–744. 48 indexed citations

Gitter, Bruce D., D. Regoli, J. Jeffry Howbert, Andrew L. Glasebrook, & Diane C. Waters. (1994). Interleukin-6 secretion from human astrocytoma cells induced by substance P. Journal of Neuroimmunology. 51(1). 101–108. 68 indexed citations

Picard, Pierre, Sylvie Boucher, D. Regoli, et al.. (1993). Use of non-peptide tachykinin receptor antagonists to substantiate the involvement of NK1 and NK2 receptors in a spinal nociceptive reflex in the rat. European Journal of Pharmacology. 232(2-3). 255–261. 47 indexed citations

Rasmussen, K., Janet F. Czachura, Marsha E. Stockton, & J. Jeffry Howbert. (1993). Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.. Journal of Pharmacology and Experimental Therapeutics. 264(1). 480–488. 48 indexed citations

10.

Ehlhardt, William J., H. R. Sullivan, Paul G. Wood, et al.. (1993). Pharmacokinetics of the Anticancer Agent Sulofenur in Mice, Rats, Monkeys, and Dogs. Journal of Pharmaceutical Sciences. 82(7). 683–688. 5 indexed citations

11.

Rasmussen, Kurt, J. Jeffry Howbert, & Marsha E. Stockton. (1993). Inhibition of A9 and A10 dopamine cells by the cholecystokinin‐B antagonist LY262691: Mediation through feedback pathways from forebrain sites. Synapse. 15(2). 95–103. 14 indexed citations

12.

Ehlhardt, William J., John F. Worzalla, Jesse R. Bewley, et al.. (1992). Comparison of metabolism and toxicity to the structure of the anticancer agent sulofenur and related sulfonylureas. Chemical Research in Toxicology. 5(5). 667–673. 13 indexed citations

13.

Gitter, Bruce D., et al.. (1991). Selectivity and specificity of new, non-peptide, quinuclidine antagonists of substance P. Biochemical and Biophysical Research Communications. 176(2). 894–901. 41 indexed citations

14.

Rasmussen, Kurt, Marsha E. Stockton, Janet F. Czachura, & J. Jeffry Howbert. (1991). Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity. European Journal of Pharmacology. 209(1-2). 135–138. 43 indexed citations

15.

Bruns, Robert F., Freeman D. Miller, Ronald L. Merriman, et al.. (1991). Inhibition of protein kinase C by calphostin C is light-dependent. Biochemical and Biophysical Research Communications. 176(1). 288–293. 348 indexed citations

16.

Ehlhardt, William J. & J. Jeffry Howbert. (1991). Metabolism and disposition of p-chloroaniline in rat, mouse, and monkey.. Drug Metabolism and Disposition. 19(2). 366–369. 28 indexed citations

17.

Houghton, Peter J., et al.. (1990). Studies on the cellular pharmacology of N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl)-urea. Biochemical Pharmacology. 39(7). 1187–1192. 27 indexed citations

18.

Howbert, J. Jeffry, Thomas A. Crowell, Richard W. Harper, et al.. (1990). Novel agents effective against solid tumors: the diarylsulfonylureas. Synthesis, activities, and analysis of quantitative structure-activity relationships. Journal of Medicinal Chemistry. 33(9). 2393–2407. 115 indexed citations

19.

Schultz, Richard M., J. Jeffry Howbert, & Robert A. Archer. (1989). Potent Inhibition of Interleukin 1β-Mediated Human Melanoma (A375.6) Lysis by Corticosteroids, Staurosporine, and Tilorone. Immunopharmacology and Immunotoxicology. 11(2-3). 489–506. 5 indexed citations

20.

Houghton, Peter J., et al.. (1989). Evaluation of N-(5-indanylsulfonyl)-N?-(4-chlorophenyl)-urea against xenografts of pediatric rhabdomyosarcoma. Cancer Chemotherapy and Pharmacology. 25(2). 84–88. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact